Headaches and the N95 face-mask amongst healthcare providers

Acta Neurol Scand. 2006 Mar;113(3):199-202. doi: 10.1111/j.1600-0404.2005.00560.x.

Abstract

Background: During the 2003 severe acute respiratory distress syndrome epidemic, healthcare workers mandatorily wore the protective N95 face-mask.

Methods: We administered a survey to healthcare workers to determine risk factors associated with development of headaches (frequency, headache subtypes and duration of face-mask wear) and the impact of headaches (sick days, headache frequency and use of abortive/preventive headache medications).

Results: In the survey, 212 (47 male, 165 female) healthcare workers of mean age 31 years (range, 21-58) participated. Of the 79 (37.3%) respondents who reported face-mask-associated headaches, 26 (32.9%) reported headache frequency exceeding six times per month. Six (7.6%) had taken sick leave from March 2003 to June 2004 (mean 2 days; range 1-4 days) and 47 (59.5%) required use of abortive analgesics because of headache. Four (2.1%) took preventive medications for headaches during this period. Multivariate logistic regression showed that pre-existing headaches [P = 0.041, OR = 1.97 (95% CI 1.03-3.77)] and continuous use of the N95 face-mask exceeding 4 h [P = 0.053, OR = 1.85 (95% CI 0.99-3.43)] were associated with development of headaches.

Conclusions: Healthcare providers may develop headaches following the use of the N95 face-mask. Shorter duration of face-mask wear may reduce the frequency and severity of these headaches.

MeSH terms

  • Adult
  • Analgesics / therapeutic use
  • Disease Outbreaks
  • Face
  • Female
  • Headache / drug therapy
  • Headache / etiology*
  • Health Personnel
  • Health Surveys
  • Humans
  • Male
  • Middle Aged
  • Occupational Exposure*
  • Respiratory Protective Devices / adverse effects*
  • Risk Factors
  • Severe Acute Respiratory Syndrome / epidemiology

Substances

  • Analgesics